cbdMD, Inc. (YCBD) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-15

Key Insights

The company's board of directors granted restricted stock units (RSUs) to independent directors and a non-management employee director as compensation for their services.
The board also approved annual cash retainers and additional fees for the independent directors, including the chairman and committee chairs.
The granting of RSUs and approval of director compensation suggest the company is focused on retaining and rewarding its board members.

Want the newest filings?

This analysis covers the filing from 2026-04-15. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-14

cbdMD has acquired the assets of Gaia Botanicals, including its popular online CBD marketplace, Bluebird Botanicals, expanding the company's product portfolio and customer reach.
The acquisition was financed through the issuance of 425,000 shares of cbdMD's restricted common stock, with an additional earnout of up to 525,000 shares based on certain performance targets.
The transaction provides cbdMD with a well-established CBD brand and e-commerce platform, potentially strengthening its competitive position in the growing CBD market.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.